Insider Trading Alert - GPN, MSON And CMS Traded By Insiders - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 12, 2015, 64 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $46,952,213.79.

Highlighted Stocks Traded by Insiders:

Global Payments (GPN) - FREE Research Report

Sacchi Guido Francesco, who is EVP and CIO at Global Payments, sold 1,200 shares at $90.30 on Feb. 12, 2015. Following this transaction, the EVP and CIO owned 14,545 shares meaning that the stake was reduced by 7.62% with the 1,200-share transaction.

Elliott Jane Marie, who is EVP and Chief Of Staff at Global Payments, sold 1,250 shares at $89.44 on Feb. 12, 2015. Following this transaction, the EVP and Chief Of Staff owned 9,007 shares meaning that the stake was reduced by 12.19% with the 1,250-share transaction.

The shares most recently traded at $91.83, up $2.39, or 2.6% since the insider transaction. Historical insider transactions for Global Payments go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 9,600
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 10,800
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 18,938

The average volume for Global Payments has been 562,100 shares per day over the past 30 days. Global Payments has a market cap of $6.1 billion and is part of the services sector and diversified services industry. Shares are up 14.18% year-to-date as of the close of trading on Thursday.

Global Payments Inc. provides electronic payments transaction processing services. The company operates in two segments, North America Merchant Services and International Merchant Services. The stock currently has a dividend yield of 0.09%. The company has a P/E ratio of 24.6. Currently, there are 6 analysts who rate Global Payments a buy, no analysts rate it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GPN - FREE

TheStreet Quant Ratings

rates Global Payments as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Global Payments Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Misonix (MSON) - FREE Research Report

Zaremba Richard A, who is Senior Vice President and CFO at Misonix, sold 8,775 shares at $13.06 on Feb. 12, 2015. Following this transaction, the Senior Vice President and CFO owned 129,326 shares meaning that the stake was reduced by 6.35% with the 8,775-share transaction.

Minetti T Guy, who is Director at Misonix, bought 15,000 shares at $5.87 on Feb. 12, 2015. Following this transaction, the Director owned 77,000 shares meaning that the stake was boosted by 24.19% with the 15,000-share transaction.

The shares most recently traded at $13.00, up $7.13, or 54.85% since the insider transaction. Historical insider transactions for Misonix go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 9,289
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 9,289
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 26,419

The average volume for Misonix has been 25,400 shares per day over the past 30 days. Misonix has a market cap of $98.7 million and is part of the health care sector and health services industry. Shares are up 4.04% year-to-date as of the close of trading on Thursday.

Misonix, Inc., a surgical device company, designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company has a P/E ratio of 34.9. Currently, there are no analysts who rate Misonix a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSON - FREE

TheStreet Quant Ratings

rates Misonix as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Misonix Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CMS Energy (CMS) - FREE Research Report

Harvey William D, who is Director at CMS Energy, bought 2,000 shares at $35.71 on Feb. 12, 2015. Following this transaction, the Director owned 11,781 shares meaning that the stake was boosted by 20.45% with the 2,000-share transaction.

The shares most recently traded at $34.98, down $0.73, or 2.07% since the insider transaction. Historical insider transactions for CMS Energy go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 4,000

The average volume for CMS Energy has been 2.2 million shares per day over the past 30 days. CMS Energy has a market cap of $9.8 billion and is part of the utilities sector and utilities industry. Shares are up 2.24% year-to-date as of the close of trading on Thursday.

CMS Energy Corporation, through its subsidiaries, operates as an energy company primarily in Michigan, the United States. The company operates in three segments: Electric Utility, Gas Utility, and Enterprises. The stock currently has a dividend yield of 3.26%. The company has a P/E ratio of 20.4. Currently, there are 6 analysts who rate CMS Energy a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMS - FREE

TheStreet Quant Ratings

rates CMS Energy as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, solid stock price performance and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

CMS Energy Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null